⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
Global Exosome-Based Therapeutics Market Size, Share, Trends, and Forecast, 2026-2033 | Engineered Platforms and Scalable Manufacturing Fuel 18.66% CAGR to USD 220.20 Million
globenewswire.com
CAPR
Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress
globenewswire.com
CAPR
Lifshitz Law PLLC Announces Investigations of Rackspace Technology, Inc. (NASDAQ: RXT), Capricor Therapeutics, Inc. (NASDAQ: CAPR), Bloom Energy Corporation (NYSE: BE), and TruGolf Holdings, Inc. (NASDAQ: TRUG)
accessnewswire.com
RXT
CAPR
BE
TRUG
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
CAPR
Pomerantz Law Firm Announces The Filing of a Class Action Against Capricor Therapeutics, Inc. and Certain Officers - CAPR
accessnewswire.com
CAPR
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline
accessnewswire.com
CAPR
Class Action Reminder from Pomerantz LLP for Shareholders of Capricor Therapeutics, Inc. – CAPR
accessnewswire.com
CAPR
Lost Money on Capricor Therapeutics, Inc. (CAPR)? Urged to Join Class Action Before September 28, 2026 - Contact Levi & Korsinsky
accessnewswire.com
CAPR
CAPR DEADLINE - FINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
CAPR
September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky
accessnewswire.com
CAPR